FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology. Value of the local echographic thickening of the ciliochoroidal region and the relative number of natural killer CD16+CD56+ in the peripheral blood are determined. If the local echographic thickening of the ciliochoroidal region by 1 mm and more, the relative number of natural killer CD16+CD56+ more than 16 % is diagnosed with initial melanoma of ciliochoroidal localization, local echographic thickening of ciliochoroidal region of less than 1 mm, relative number of natural killer CD16+CD56+ less than 8.2 % – chronic iridocyclitis.
EFFECT: method enables selecting a timely, adequate treatment of melanoma of ciliochoroidal localization and chronic iridocyclitis.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF UNFAVOURABLE COURSE OF UVEAL MELANOMA | 2018 |
|
RU2698797C1 |
| METHOD FOR PREDICTION OF UNFAVORABLE COURSE OF CHRONIC POST-TRAUMATIC UVEITIS AFTER SINGLE PENETRATING SURGICAL INTERVENTION ON EYEBALL | 2020 |
|
RU2733745C1 |
| METHOD FOR PREDICTING THE COURSE OF THE INITIAL CHOROIDAL MELANOMA | 2017 |
|
RU2645644C1 |
| METHOD FOR DIAGNOSING PREVALENCE OF NEOPLASTIC PROCESS IN PRE-EQUATORIAL ZONE OF FUNDUS | 2023 |
|
RU2807528C1 |
| METHOD FOR THE DIFFERENTIAL DIAGNOSIS OF MELANOMA OF THE CHOROID OF THE CENTRAL LOCALIZATION AND THE LATE STAGE OF AGE-RELATED MACULAR DEGENERATION | 2022 |
|
RU2792554C1 |
| METHOD FOR DETERMINING INDICATIONS FOR THE REPEATED DESTRUCTION OF THE INITIAL MELANOMA OF CHOROID | 2017 |
|
RU2665185C1 |
| METHOD OF DIFFERENTIAL DIAGNOSIS OF IRIS MELANOMA AND PROGRESSIVE IRIS NEVUS | 2023 |
|
RU2799919C1 |
| METHOD OF TREATING UVEAL MELANOMA | 2000 |
|
RU2175242C1 |
| METHOD FOR ULTRASOUND DIAGNOSIS OF INVASION OF JUXTAPAPILLARY UVEAL MELANOMA (UM) INTO THE INTRABULBAR PART OF THE OPTIC NERVE | 2023 |
|
RU2807527C1 |
| TUMOUR SUPPRESSION WITH USE OF HUMAN PLACENTAL PERFUSATE AND AUXILIARY NATURAL KILLER CELLS RECOVERED FROM HUMAN PLACENTA | 2008 |
|
RU2536242C2 |
